OR WAIT null SECS
October 12, 2010
An annual analysis rates the performance of pharmaceutical and biotechnology companies in corporate sustainability.
World leaders gathered at the United Nations last month to review the progress and map out a strategy for achieving the Millennium Development Goals.
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
October 02, 2010
A look at MVI's malaria work in developing countries.
September 01, 2010
Despite the poor economic climate, large-scale mergers and acquisitions in the pharmaceutical industry struck back with a vengeance in 2009.
An upcoming summit will assess the progress and gaps in realizing the UN Millennium Development Goals, including outcomes from global health initiatives.
A roundup of developments on corporate social responsibility from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Secretary of State Hillary Clinton details the progress and future direction of the US role in the Global Health Initiative.
August 04, 2010
The UN Global Compact, a corporate-social-responsibility initiative, releases a management model to help businesses implement sustainability principles.